CYCLACEL PHARMACEUTICALS INC's ticker is CYCCP and the CUSIP is 23254L207. A total of 3 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $120 | – | 10 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 10 | -76.2% | 0.00% | – |
| Q3 2017 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 42 | -90.1% | 0.00% | – |
| Q1 2017 | $3,000 | – | 423 | +1181.8% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 33 | -90.1% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 333 | -11.9% | 0.00% | – |
| Q2 2016 | $2,000 | -33.3% | 378 | -27.2% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 519 | -13.6% | 0.00% | – |
| Q4 2015 | $2,000 | -50.0% | 601 | -25.1% | 0.00% | – |
| Q3 2015 | $4,000 | +300.0% | 802 | +915.2% | 0.00% | – |
| Q2 2015 | $1,000 | – | 79 | +21.5% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 65 | -83.5% | 0.00% | – |
| Q4 2014 | $2,000 | – | 395 | +690.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 50 | -94.2% | 0.00% | -100.0% |
| Q2 2014 | $6,000 | +200.0% | 856 | +307.6% | 0.00% | – |
| Q1 2014 | $2,000 | – | 210 | +950.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 20 | -70.1% | 0.00% | – |
| Q3 2013 | $1,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,253 | $92,000 | 0.00% |
| UBS Group AG | 570 | $4,000 | 0.00% |